The EPS projection of Benefitfocus, Inc. (NASDAQ:BNFT) for quarter ended 2016-09-30 is $-0.41. Last week, the EPS forecast was $-0.41 against target of $-0.41, a month earlier. Two months ago, this estimate was $-0.41 versus forecast of $-0.41 three months earlier, implying a deviation of 0%.
Benefitfocus, Inc. (NASDAQ:BNFT) stated that 18 days ago, its stock price was positively revised 4 times while negative revisions were 0.
In last week, the experts lowered EPS 0 times and increased EPS 0 times. In last 30, 120, 60 and 90 days, the experts upped revisions 0 , 0, 0, and 0, correspondingly.
EPS estimate downgrade for Benefitfocus, Inc. (NASDAQ:BNFT) in the preceding 30, 120, 60 and 90 days were 0, 4, 4, and 4, correspondingly.
Benefitfocus, Inc. (NASDAQ:BNFT) EPS target for the quarter closed 1 was $-0.41, based on 5 recommendations. As reported on 2016-05-04 the EPS was $-0.46. The change was $0.04, implying a percentage deviation of 8%. The projections showed a standard deviation of 0.02.
Quarterly Sales Estimates
Benefitfocus, Inc. (NASDAQ:BNFT) yearly sales prediction for the fiscal 2017 stands at $79.5 and the median estimate is at $77.75. Almost 3 analysts issued sales target.
Highest sales target is $83.95 while the lowest target is $76.8 showing standard deviation of 3.882%.
As many as 3 analysts have sales targets revised upside while 3 reduced sales estimates, implying a deviation of 0%.
Last month, 3 revised sales number projection on upside while 3 lowered the sales projections, implying a deviation of 0%.
A quarter ago, 3 hiked sales target and 3 reduced sales forecast. Benefitfocus, Inc. (NASDAQ:BNFT) announced that the deviation in forecast was -3.518%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...